Ablatus secures investment from Keiretsu Forum London Angels for its Luna treatment platform.
Cambridge-based femtech Ablatus has secured backing from Keiretsu Forum London Angels to support its soft tissue treatment technology.
Cambridge-based medical technology company Ablatus develops Luna, a treatment system for soft tissues such as tumours and fibroids.
Cambridge-based femtech company Ablatus has secured backing from Keiretsu Forum London Angels for its Luna treatment platform. The company is developing technology aimed at improving the treatment of soft tissues, including tumours and fibroids.
The capital from this round will support founder Chung Looi and the team as they advance their medical technology offerings.
